A 12-week randomized open-label study of dermatological precautions with lamotrigine in bipolar disorder patients

被引:0
|
作者
Ketter, TA
Graham, J
Thompson, T
Nanry, K
机构
[1] Stanford Univ, Dept Psychiat, Palo Alto, CA 94304 USA
[2] GlaxoSmithKline Inc, Neurosci MDC, Res Triangle Pk, NC USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:176 / 176
页数:1
相关论文
共 50 条
  • [41] An Open-Label Study of Aripiprazole in Children with a Bipolar Disorder
    Findling, Robert L.
    McNamara, Nora K.
    Youngstrom, Eric A.
    Stansbrey, Robert J.
    Frazier, Thomas W.
    Lingler, Jacqui
    Otto, Benjamin D.
    Demeter, Christine A.
    Rowles, Brieana M.
    Calabrese, Joseph R.
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2011, 21 (04) : 345 - 351
  • [42] An open-label study of ziprasidone in children with bipolar disorder
    Biederman, J
    Harpold, T
    Hammerness, P
    Mick, E
    Dougherty, M
    Aleardi, M
    Randall, E
    [J]. BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 106S - 107S
  • [43] Effects of Ezetimibe on Glucose Metabolism in Patients With Type 2 Diabetes: A 12-Week, Open-Label, Uncontrolled, Pilot Study
    Nozue, Tsuyoshi
    Michishita, Ichiro
    Mizuguchi, Ichiro
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2010, 71 (04): : 252 - 258
  • [44] Reboxetine Adjuvant Therapy in Patients With Schizophrenia Showing a Suboptimal Response to Clozapine A 12-Week, Open-Label, Pilot Study
    Bruno, Antonio
    Zoccali, Rocco
    Bellinghieri, Paolo Micali
    Pandolfo, Gianluca
    De Fazio, Pasquale
    Spina, Edoardo
    Muscatello, Maria Rosaria A.
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 34 (05) : 620 - 623
  • [45] A 12-week comparative prospective open-label randomized controlled study in depression patients treated with vilazodone and escitalopram in a tertiary care hospital in North India
    Bathla, Manish
    Anjum, Shazia
    Singh, Manpreet
    Panchal, Saminder
    Singh, Gurvinder Pal
    [J]. INDIAN JOURNAL OF PSYCHOLOGICAL MEDICINE, 2018, 40 (01) : 80 - 85
  • [46] Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea - A 12-week, open-label study
    Schwartz, JRL
    Hirshkowitz, M
    Erman, MK
    Schmidt-Nowara, W
    [J]. CHEST, 2003, 124 (06) : 2192 - 2199
  • [47] An open-label study of lamotrigine adjunct or monotherapy for the treatment of adolescents with bipolar depression
    Chang, K
    Saxena, K
    Howe, M
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2006, 45 (03): : 298 - 304
  • [48] Aripiprazole in Children with Tourette's Disorder and Co-morbid Attention-Deficit/Hyperactivity Disorder: A 12-Week, Open-Label, Preliminary Study
    Masi, Gabriele
    Gagliano, Antonella
    Siracusano, Rosamaria
    Berloffa, Stefano
    Calarese, Tiziana
    Ilardo, Giovanna
    Pfanner, Chiara
    Magazu, Angela
    Cedro, Clemente
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2012, 22 (02) : 120 - 125
  • [49] LURASIDONE IN THE LONG-TERM TREATMENT OF PATIENTS WITH BIPOLAR DISORDER: A 24-WEEK OPEN-LABEL EXTENSION STUDY
    Ketter, Terence A.
    Sarma, Kaushik
    Silva, Robert
    Kroger, Hans
    Cucchiaro, Josephine
    Loebel, Antony
    [J]. DEPRESSION AND ANXIETY, 2016, 33 (05) : 424 - 434
  • [50] Varenicline for Smoking Cessation in Schizophrenia: Safety and Effectiveness in a 12-Week Open-Label Trial
    Pachas, Gladys N.
    Cather, Corinne
    Pratt, Sarah I.
    Hoeppner, Bettina
    Nino, Johanna
    Carlini, Sara V.
    Achtyes, Eric D.
    Lando, Harry
    Mueser, Kim T.
    Rigotti, Nancy A.
    Goff, Donald C.
    Evins, A. Eden
    [J]. JOURNAL OF DUAL DIAGNOSIS, 2012, 8 (02) : 117 - 125